Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
184A1
NM
Basal
Valproic acid
HDAC
HDAC
12509.143
uM
612.3160
1000.00000
-0.4448 -0.3207 1.0103 0.2717
0.9441
1.3392
184A1
NM
Basal
Vinorelbine
TUBB
TUBB
7787.018
uM
inf
inf
-0.9963 -0.9963 0.0000 0.4831
0.4499
0.3791
184A1
NM
Basal
Vorinostat
HDAC
HDAC
5894.065
uM
174.64490
418.8430
-0.3946 -0.4684 0.7558 0.4201
0.9859
1.6064
184A1
NM
Basal
Vorinostat
HDAC
HDAC
5895.065
uM
141.55360
735.01640
-0.6699 -0.8793 0.6160 0.4840
0.9909
1.3748
184A1
NM
Basal
XRP44X
ELK3
MAPK
12509.157
uM
0.40211
0.13495
0.3462 0.3842 1.3397 0.3328
0.9859
1.2837
184A1
NM
Basal
ZM-447439
AURK
AURK
12509.169
uM
inf
1.20210
0.5422 0.5277 0.9240 0.1592
0.9369
1.5064
184B5
NM
Basal
17-AAG
HSP90
HSP90
9095.037
uM
0.02221
0.02925
-0.9385 -0.7659 3.3756 1.0941
0.9910
1.0013
184B5
NM
Basal
2-deoxyglucose
12979.177
uM
559.39550
583.2410
-0.1158 -0.1161 5.0000 0.2148
0.7107
0.5647
184B5
NM
Basal
5-DFUR
TYMS
TYMS
12566.143
uM
303.43380
999.99910
0.1514 -0.2734 0.3658 0.2766
0.9906
1.6413
184B5
NM
Basal
Afatinib
EGFR/HER2
ErbB
12566.165
uM
0.11327
1.15330
-0.8618 -1.0000 0.4734 0.6795
0.9291
1.7248
184B5
NM
Basal
AG1024
IGF1R
RTK
5897.066
uM
0.22173
0.22268
-0.1723 -0.0108 4.9920 0.3762
0.9612
1.2737
184B5
NM
Basal
AG1024
IGF1R
RTK
5896.066
uM
0.20947
0.20891
-0.1513 0.0066 4.9829 0.4028
0.9686
1.4224
184B5
NM
Basal
AS-252424
PI3K
PI3K
12566.165
uM
26.52190
125.8320
0.4159 -1.0000 0.7056 0.0982
0.8944
1.7248
184B5
NM
Basal
Baicalein
Lipoxygenase
Metabolism
5897.073
uM
259.94010
173.29010
0.7393 0.4284 4.7935 -0.0004
0.8982
1.2323
184B5
NM
Basal
Bortezomib
Proteasome
Proteasome
5897.074
uM
0.02546
0.03680
-0.7949 -0.6246 2.1998 1.0567
0.9711
1.2824
184B5
NM
Basal
Bortezomib
Proteasome
Proteasome
5897.074
uM
0.02546
0.03680
-0.7949 -0.6246 2.1998 1.0567
0.9711
1.2824
184B5
NM
Basal
Bortezomib
Proteasome
Proteasome
5896.074
uM
0.01517
0.03188
-0.7992 -0.7384 1.2208 1.1454
0.9925
1.4124
184B5
NM
Basal
Bortezomib
Proteasome
Proteasome
5896.074
uM
0.01517
0.03188
-0.7992 -0.7384 1.2208 1.1454
0.9925
1.4124
184B5
NM
Basal
Bosutinib
Src
nRTK
12566.17
uM
0.54836
0.85384
-0.2865 -0.3368 1.1630 0.4044
0.9933
1.4648
184B5
NM
Basal
Bromopyruvic acid
Hexokinase II
Metabolism
12979.177
uM
0.02740
0.03413
-1.0000 -1.0000 5.0000 1.0789
0.9988
0.5647
184B5
NM
Basal
Carboplatin
DNA cross-linker
DNA cross-linker
9095.119
uM
5.77830
14.25320
-0.9033 -0.9300 1.1638 0.6853
0.9882
1.2263
184B5
NM
Basal
Cetuximab
EGFR
ErbB
9095.026
uM
0.04089
0.03186
0.1205 0.1008 0.9024 0.1873
0.9743
1.0168
184B5
NM
Basal
CGC-11047
Polyamine analogue
9095.026
uM
486.65450
602.90190
-0.9562 -0.9592 5.0000 0.3089
0.9969
1.0168
184B5
NM
Basal
Chloroquine
12979.177
uM
19.64650
24.47430
-1.0000 -1.0000 5.0000 0.1512
0.9526
0.5647
184B5
NM
Basal
Cisplatin
DNA cross-linker
DNA cross-linker
9095.049
uM
inf
193.58440
0.7160 0.7080 3.7384 0.0137
0.8937
1.1202